Reports

Industry Research Reports

Global Meso Scale Discovery (MSD) Assay Services Market Outlook, In‑Depth Analysis & Forecast to 2032

Global Meso Scale Discovery (MSD) Assay Services Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Service & Software

Published Date: 2026-03-26

Pages: 138 Pages

Report ld: 6342161

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global Meso Scale Discovery (MSD) Assay Services market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.

An Meso Scale Discovery (MSD) Assay Services provide high-sensitivity, multiplex immunoassays for the quantitative measurement of biomarkers, proteins, and other analytes in biological samples. MSD assays are based on electrochemiluminescence detection, which offers several advantages over traditional ELISA, including increased sensitivity, a broader dynamic range, and the ability to measure multiple analytes simultaneously.

From a downstream perspective, Pharmaceutical Research accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).

Meso Scale Discovery (MSD) Assay Services leading players (including Chimera Biotec, Reaction Biology, NorthEast BioAnalytical Laboratories LLC, Creative Proteomics, Pestka Biomedical Laboratories, Inc, Precision Medicine Group, LLC, CellCarta, ImmunoDiagnostics Limited, Alcyomics Ltd, IMMUNOLOGIX, etc.), dominate supply; the top five capture approximately % of global revenue, with Chimera Biotec leading 2025 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Meso Scale Discovery (MSD) Assay Services market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Chimera Biotec
  • Reaction Biology
  • NorthEast BioAnalytical Laboratories LLC
  • Creative Proteomics
  • Pestka Biomedical Laboratories, Inc
  • Precision Medicine Group, LLC
  • CellCarta
  • ImmunoDiagnostics Limited
  • Alcyomics Ltd
  • IMMUNOLOGIX
  • Novogene
  • Guidon Pharmaceutics
  • MEDx Translational Medicine Co., Ltd

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • S-Plex Technology
  • V-Plex Technology
  • Other

Segment by Application

  • Pharmaceutical Research
  • Clinical Diagnostics
  • Biomarker Discovery
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the Meso Scale Discovery (MSD) Assay Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves

marn_i1

Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application

marn_i1

Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers

marn_i1

Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers

marn_i1

Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas

marn_i1

Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges

marn_i1

Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments

marn_i1

Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels

marn_i1

Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies

marn_i1

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to Meso Scale Discovery (MSD) Assay Services: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Meso Scale Discovery (MSD) Assay Services Market Size by Type, 2021 vs 2025 vs 2032

1.2.2 S-Plex Technology

1.2.3 V-Plex Technology

1.2.4 Other

1.3 Market Segmentation by Application

1.3.1 Global Meso Scale Discovery (MSD) Assay Services Market Size by Application, 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical Research

1.3.3 Clinical Diagnostics

1.3.4 Biomarker Discovery

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global Meso Scale Discovery (MSD) Assay Services Revenue Estimates and Forecasts (2021-2032)

2.2 Global Meso Scale Discovery (MSD) Assay Services Revenue by Region

2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032

2.2.2 Historical and Forecasted Revenue by Region (2021-2032)

2.2.3 Global Revenue-Based Market Share by Region (2021-2032)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

muLu

3 Competitive Landscape

3.1 Global Meso Scale Discovery (MSD) Assay Services Players’ Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2021-2026)

3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Players (2021 vs 2025)

3.2 Global Meso Scale Discovery (MSD) Assay Services Companies Headquarters and Service Footprint

3.3 Key Player Market Share by Product Type

3.3.1 S-Plex Technology: Market Share by Key Players

3.3.2 V-Plex Technology: Market Share by Key Players

3.3.3 Other: Market Share by Key Players

3.4 Global Meso Scale Discovery (MSD) Assay Services Market Concentration and Dynamics

3.4.1 Global Market Concentration

3.4.2 Market Entry and Exit Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

muLu

4 Product Segmentation

4.1 Global Meso Scale Discovery (MSD) Assay Services Market by Type

4.1.1 Global Revenue by Type (2021-2032)

4.1.2 Global Revenue-Based Market Share by Type (2021-2032)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

muLu

5 Downstream Applications and Customers

5.1 Global Meso Scale Discovery (MSD) Assay Services Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)

5.1.2 Revenue-Based Market Share by Application (2021-2032)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

muLu

6 North America

6.1 North America Market Size (2021-2032)

6.2 North America Key Players’ Revenue in 2025

6.3 North America Meso Scale Discovery (MSD) Assay Services Market Size by Application (2021-2032)

6.4 North America Growth Accelerators and Market Barriers

6.5 North America Meso Scale Discovery (MSD) Assay Services Market Size by Country

6.5.1 North America Revenue Trends by Country

6.5.2 US

6.5.3 Canada

6.5.4 Mexico

muLu

7 Europe

7.1 Europe Market Size (2021-2032)

7.2 Europe Key Players’ Revenue in 2025

7.3 Europe Meso Scale Discovery (MSD) Assay Services Market Size by Application (2021-2032)

7.4 Europe Growth Accelerators and Market Barriers

7.5 Europe Meso Scale Discovery (MSD) Assay Services Market Size by Country

7.5.1 Europe Revenue Trends by Country

7.5.2 Germany

7.5.3 France

7.5.4 U.K.

7.5.5 Italy

7.5.6 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2021-2032)

8.2 Asia-Pacific Key Players’ Revenue in 2025

8.3 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Size by Application (2021-2032)

8.4 Asia-Pacific Growth Accelerators and Market Barriers

8.5 Asia-Pacific Meso Scale Discovery (MSD) Assay Services Market Size by Region

8.5.1 Asia-Pacific Revenue Trends by Region

8.6 China

8.7 Japan

8.8 South Korea

8.9 Australia

8.10 India

8.11 Southeast Asia

8.11.1 Indonesia

8.11.2 Vietnam

8.11.3 Malaysia

8.11.4 Philippines

8.11.5 Singapore

muLu

9 Central and South America

9.1 Central and South America Market Size (2021-2032)

9.2 Central and South America Key Players’ Revenue in 2025

9.3 Central and South America Meso Scale Discovery (MSD) Assay Services Market Size by Application (2021-2032)

9.4 Central and South America Investment Opportunities and Key Challenges

9.5 Central and South America Meso Scale Discovery (MSD) Assay Services Market Size by Country

9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)

9.5.2 Brazil

9.5.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2021-2032)

10.2 Middle East and Africa Key Players’ Revenue in 2025

10.3 Middle East and Africa Meso Scale Discovery (MSD) Assay Services Market Size by Application (2021-2032)

10.4 Middle East and Africa Investment Opportunities and Key Challenges

10.5 Middle East and Africa Meso Scale Discovery (MSD) Assay Services Market Size by Country

10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)

10.5.2 GCC Countries

10.5.3 Israel

10.5.4 Egypt

10.5.5 South Africa

muLu

11 Corporate Profile

11.1 Chimera Biotec

11.1.1 Chimera Biotec Corporation Information

11.1.2 Chimera Biotec Business Overview

11.1.3 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.1.4 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.1.5 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2025

11.1.6 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2025

11.1.7 Chimera Biotec Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2025

11.1.8 Chimera Biotec Meso Scale Discovery (MSD) Assay Services SWOT Analysis

11.1.9 Chimera Biotec Recent Developments

11.2 Reaction Biology

11.2.1 Reaction Biology Corporation Information

11.2.2 Reaction Biology Business Overview

11.2.3 Reaction Biology Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.2.4 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.2.5 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2025

11.2.6 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2025

11.2.7 Reaction Biology Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2025

11.2.8 Reaction Biology Meso Scale Discovery (MSD) Assay Services SWOT Analysis

11.2.9 Reaction Biology Recent Developments

11.3 NorthEast BioAnalytical Laboratories LLC

11.3.1 NorthEast BioAnalytical Laboratories LLC Corporation Information

11.3.2 NorthEast BioAnalytical Laboratories LLC Business Overview

11.3.3 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.3.4 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.3.5 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2025

11.3.6 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2025

11.3.7 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2025

11.3.8 NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services SWOT Analysis

11.3.9 NorthEast BioAnalytical Laboratories LLC Recent Developments

11.4 Creative Proteomics

11.4.1 Creative Proteomics Corporation Information

11.4.2 Creative Proteomics Business Overview

11.4.3 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.4.4 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.4.5 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2025

11.4.6 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2025

11.4.7 Creative Proteomics Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2025

11.4.8 Creative Proteomics Meso Scale Discovery (MSD) Assay Services SWOT Analysis

11.4.9 Creative Proteomics Recent Developments

11.5 Pestka Biomedical Laboratories, Inc

11.5.1 Pestka Biomedical Laboratories, Inc Corporation Information

11.5.2 Pestka Biomedical Laboratories, Inc Business Overview

11.5.3 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.5.4 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.5.5 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue by Product in 2025

11.5.6 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue by Application in 2025

11.5.7 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services Revenue by Geographic Area in 2025

11.5.8 Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services SWOT Analysis

11.5.9 Pestka Biomedical Laboratories, Inc Recent Developments

11.6 Precision Medicine Group, LLC

11.6.1 Precision Medicine Group, LLC Corporation Information

11.6.2 Precision Medicine Group, LLC Business Overview

11.6.3 Precision Medicine Group, LLC Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.6.4 Precision Medicine Group, LLC Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.6.5 Precision Medicine Group, LLC Recent Developments

11.7 CellCarta

11.7.1 CellCarta Corporation Information

11.7.2 CellCarta Business Overview

11.7.3 CellCarta Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.7.4 CellCarta Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.7.5 CellCarta Recent Developments

11.8 ImmunoDiagnostics Limited

11.8.1 ImmunoDiagnostics Limited Corporation Information

11.8.2 ImmunoDiagnostics Limited Business Overview

11.8.3 ImmunoDiagnostics Limited Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.8.4 ImmunoDiagnostics Limited Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.8.5 ImmunoDiagnostics Limited Recent Developments

11.9 Alcyomics Ltd

11.9.1 Alcyomics Ltd Corporation Information

11.9.2 Alcyomics Ltd Business Overview

11.9.3 Alcyomics Ltd Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.9.4 Alcyomics Ltd Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.9.5 Alcyomics Ltd Recent Developments

11.10 IMMUNOLOGIX

11.10.1 IMMUNOLOGIX Corporation Information

11.10.2 IMMUNOLOGIX Business Overview

11.10.3 IMMUNOLOGIX Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.10.4 IMMUNOLOGIX Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.10.5 Company Ten Recent Developments

11.11 Novogene

11.11.1 Novogene Corporation Information

11.11.2 Novogene Business Overview

11.11.3 Novogene Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.11.4 Novogene Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.11.5 Novogene Recent Developments

11.12 Guidon Pharmaceutics

11.12.1 Guidon Pharmaceutics Corporation Information

11.12.2 Guidon Pharmaceutics Business Overview

11.12.3 Guidon Pharmaceutics Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.12.4 Guidon Pharmaceutics Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.12.5 Guidon Pharmaceutics Recent Developments

11.13 MEDx Translational Medicine Co., Ltd

11.13.1 MEDx Translational Medicine Co., Ltd Corporation Information

11.13.2 MEDx Translational Medicine Co., Ltd Business Overview

11.13.3 MEDx Translational Medicine Co., Ltd Meso Scale Discovery (MSD) Assay Services Product Features and Attributes

11.13.4 MEDx Translational Medicine Co., Ltd Meso Scale Discovery (MSD) Assay Services Revenue and Gross Margin (2021-2026)

11.13.5 MEDx Translational Medicine Co., Ltd Recent Developments

muLu

12 Meso Scale Discovery (MSD) Assay Services Value Chain and Ecosystem Analysis

12.1 Meso Scale Discovery (MSD) Assay Services Value Chain (Ecosystem Structure)

12.2 Upstream Analysis

12.2.1 Key Technologies, Platforms and Infrastructure

12.3 Midstream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 Meso Scale Discovery (MSD) Assay Services Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

muLu

14 Key Findings in the Global Meso Scale Discovery (MSD) Assay Services Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Meso Scale Discovery (MSD) Assay Services Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Meso Scale Discovery (MSD) Assay Services Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Meso Scale Discovery (MSD) Assay Services Revenue by Region (US$ Million), 2021-2026
Table 5. Global Meso Scale Discovery (MSD) Assay Services Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global Meso Scale Discovery (MSD) Assay Services Revenue by Players (US$ Million), 2021-2026
Table 8. Global Meso Scale Discovery (MSD) Assay Services Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Meso Scale Discovery (MSD) Assay Services Revenue, 2025
Table 11. Global Meso Scale Discovery (MSD) Assay Services Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global Meso Scale Discovery (MSD) Assay Services Companies Headquarters
Table 13. Global Meso Scale Discovery (MSD) Assay Services Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Meso Scale Discovery (MSD) Assay Services Revenue by Type (US$ Million), 2021-2026
Table 17. Global Meso Scale Discovery (MSD) Assay Services Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global Meso Scale Discovery (MSD) Assay Services Revenue by Application (US$ Million), 2021-2026
Table 20. Global Meso Scale Discovery (MSD) Assay Services Revenue by Application (US$ Million), 2027-2032
Table 21. Meso Scale Discovery (MSD) Assay Services High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Meso Scale Discovery (MSD) Assay Services Growth Accelerators and Market Barriers
Table 25. North America Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe Meso Scale Discovery (MSD) Assay Services Growth Accelerators and Market Barriers
Table 27. Europe Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific Meso Scale Discovery (MSD) Assay Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America Meso Scale Discovery (MSD) Assay Services Investment Opportunities and Key Challenges
Table 31. Central and South America Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa Meso Scale Discovery (MSD) Assay Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Meso Scale Discovery (MSD) Assay Services Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Chimera Biotec Corporation Information
Table 35. Chimera Biotec Description and Major Businesses
Table 36. Chimera Biotec Product Features and Attributes
Table 37. Chimera Biotec Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Chimera Biotec Revenue Proportion by Product in 2025
Table 39. Chimera Biotec Revenue Proportion by Application in 2025
Table 40. Chimera Biotec Revenue Proportion by Geographic Area in 2025
Table 41. Chimera Biotec Meso Scale Discovery (MSD) Assay Services SWOT Analysis
Table 42. Chimera Biotec Recent Developments
Table 43. Reaction Biology Corporation Information
Table 44. Reaction Biology Description and Major Businesses
Table 45. Reaction Biology Product Features and Attributes
Table 46. Reaction Biology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Reaction Biology Revenue Proportion by Product in 2025
Table 48. Reaction Biology Revenue Proportion by Application in 2025
Table 49. Reaction Biology Revenue Proportion by Geographic Area in 2025
Table 50. Reaction Biology Meso Scale Discovery (MSD) Assay Services SWOT Analysis
Table 51. Reaction Biology Recent Developments
Table 52. NorthEast BioAnalytical Laboratories LLC Corporation Information
Table 53. NorthEast BioAnalytical Laboratories LLC Description and Major Businesses
Table 54. NorthEast BioAnalytical Laboratories LLC Product Features and Attributes
Table 55. NorthEast BioAnalytical Laboratories LLC Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. NorthEast BioAnalytical Laboratories LLC Revenue Proportion by Product in 2025
Table 57. NorthEast BioAnalytical Laboratories LLC Revenue Proportion by Application in 2025
Table 58. NorthEast BioAnalytical Laboratories LLC Revenue Proportion by Geographic Area in 2025
Table 59. NorthEast BioAnalytical Laboratories LLC Meso Scale Discovery (MSD) Assay Services SWOT Analysis
Table 60. NorthEast BioAnalytical Laboratories LLC Recent Developments
Table 61. Creative Proteomics Corporation Information
Table 62. Creative Proteomics Description and Major Businesses
Table 63. Creative Proteomics Product Features and Attributes
Table 64. Creative Proteomics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Creative Proteomics Revenue Proportion by Product in 2025
Table 66. Creative Proteomics Revenue Proportion by Application in 2025
Table 67. Creative Proteomics Revenue Proportion by Geographic Area in 2025
Table 68. Creative Proteomics Meso Scale Discovery (MSD) Assay Services SWOT Analysis
Table 69. Creative Proteomics Recent Developments
Table 70. Pestka Biomedical Laboratories, Inc Corporation Information
Table 71. Pestka Biomedical Laboratories, Inc Description and Major Businesses
Table 72. Pestka Biomedical Laboratories, Inc Product Features and Attributes
Table 73. Pestka Biomedical Laboratories, Inc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Pestka Biomedical Laboratories, Inc Revenue Proportion by Product in 2025
Table 75. Pestka Biomedical Laboratories, Inc Revenue Proportion by Application in 2025
Table 76. Pestka Biomedical Laboratories, Inc Revenue Proportion by Geographic Area in 2025
Table 77. Pestka Biomedical Laboratories, Inc Meso Scale Discovery (MSD) Assay Services SWOT Analysis
Table 78. Pestka Biomedical Laboratories, Inc Recent Developments
Table 79. Precision Medicine Group, LLC Corporation Information
Table 80. Precision Medicine Group, LLC Description and Major Businesses
Table 81. Precision Medicine Group, LLC Product Features and Attributes
Table 82. Precision Medicine Group, LLC Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Precision Medicine Group, LLC Recent Developments
Table 84. CellCarta Corporation Information
Table 85. CellCarta Description and Major Businesses
Table 86. CellCarta Product Features and Attributes
Table 87. CellCarta Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. CellCarta Recent Developments
Table 89. ImmunoDiagnostics Limited Corporation Information
Table 90. ImmunoDiagnostics Limited Description and Major Businesses
Table 91. ImmunoDiagnostics Limited Product Features and Attributes
Table 92. ImmunoDiagnostics Limited Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. ImmunoDiagnostics Limited Recent Developments
Table 94. Alcyomics Ltd Corporation Information
Table 95. Alcyomics Ltd Description and Major Businesses
Table 96. Alcyomics Ltd Product Features and Attributes
Table 97. Alcyomics Ltd Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Alcyomics Ltd Recent Developments
Table 99. IMMUNOLOGIX Corporation Information
Table 100. IMMUNOLOGIX Description and Major Businesses
Table 101. IMMUNOLOGIX Product Features and Attributes
Table 102. IMMUNOLOGIX Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. IMMUNOLOGIX Recent Developments
Table 104. Novogene Corporation Information
Table 105. Novogene Description and Major Businesses
Table 106. Novogene Product Features and Attributes
Table 107. Novogene Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Novogene Recent Developments
Table 109. Guidon Pharmaceutics Corporation Information
Table 110. Guidon Pharmaceutics Description and Major Businesses
Table 111. Guidon Pharmaceutics Product Features and Attributes
Table 112. Guidon Pharmaceutics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. Guidon Pharmaceutics Recent Developments
Table 114. MEDx Translational Medicine Co., Ltd Corporation Information
Table 115. MEDx Translational Medicine Co., Ltd Description and Major Businesses
Table 116. MEDx Translational Medicine Co., Ltd Product Features and Attributes
Table 117. MEDx Translational Medicine Co., Ltd Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. MEDx Translational Medicine Co., Ltd Recent Developments
Table 119. Technologies, Platforms and Infrastructure
Table 120. Distributors List
Table 121. Market Trends and Market Evolution
Table 122. Market Drivers and Opportunities
Table 123. Market Challenges, Risks, and Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Global Meso Scale Discovery (MSD) Assay Services Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. S-Plex Technology Product Picture
Figure 3. V-Plex Technology Product Picture
Figure 4. Other Product Picture
Figure 5. Global Meso Scale Discovery (MSD) Assay Services Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Global Meso Scale Discovery (MSD) Assay Services Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Pharmaceutical Research
Figure 8. Clinical Diagnostics
Figure 9. Biomarker Discovery
Figure 10. Others
Figure 11. Meso Scale Discovery (MSD) Assay Services Report Years Considered
Figure 12. Global Meso Scale Discovery (MSD) Assay Services Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 14. Global Meso Scale Discovery (MSD) Assay Services Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Global Meso Scale Discovery (MSD) Assay Services Revenue-Based Market Share by Region (2021-2032)
Figure 16. Global Meso Scale Discovery (MSD) Assay Services Revenue-Based Market Share Ranking (2025)
Figure 17. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 18. S-Plex Technology Revenue-Based Market Share by Player in 2025
Figure 19. V-Plex Technology Revenue-Based Market Share by Player in 2025
Figure 20. Other Revenue-Based Market Share by Player in 2025
Figure 21. Global Meso Scale Discovery (MSD) Assay Services Revenue-Based Market Share by Type (2021-2032)
Figure 22. Global Meso Scale Discovery (MSD) Assay Services Revenue-Based Market Share by Application (2021-2032)
Figure 23. North America Meso Scale Discovery (MSD) Assay Services Revenue YoY (US$ Million), 2021-2032
Figure 24. North America Top 5 Players Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) in 2025
Figure 25. North America Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Application (2021-2032)
Figure 26. US Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 27. Canada Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 28. Mexico Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 29. Europe Meso Scale Discovery (MSD) Assay Services Revenue YoY (US$ Million), 2021-2032
Figure 30. Europe Top 5 Players Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) in 2025
Figure 31. Europe Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Application (2021-2032)
Figure 32. Germany Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 33. France Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 34. U.K. Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 35. Italy Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 36. Russia Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 37. Asia-Pacific Meso Scale Discovery (MSD) Assay Services Revenue YoY (US$ Million), 2021-2032
Figure 38. Asia-Pacific Top 8 Players Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) in 2025
Figure 39. Asia-Pacific Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Application (2021-2032)
Figure 40. Indonesia Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 41. Japan Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 42. South Korea Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 43. Australia Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 44. India Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 45. Indonesia Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 46. Vietnam Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 47. Malaysia Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 48. Philippines Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 49. Singapore Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 50. Central and South America Meso Scale Discovery (MSD) Assay Services Revenue YoY (US$ Million), 2021-2032
Figure 51. Central and South America Top 5 Players Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) in 2025
Figure 52. Central and South America Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Application (2021-2032)
Figure 53. Brazil Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 54. Argentina Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 55. Middle East and Africa Meso Scale Discovery (MSD) Assay Services Revenue YoY (US$ Million), 2021-2032
Figure 56. Middle East and Africa Top 5 Players Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) in 2025
Figure 57. Middle East and Africa Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million) by Application (2021-2032)
Figure 58. GCC Countries Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 59. Israel Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 60. Egypt Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 61. South Africa Meso Scale Discovery (MSD) Assay Services Revenue (US$ Million), 2021-2032
Figure 62. Meso Scale Discovery (MSD) Assay Services Value Chain Mapping
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Meso Scale Discovery (MSD) Assay Services market?zhanKai
The top companies in the global Meso Scale Discovery (MSD) Assay Services market are Chimera Biotec、Reaction Biology、NorthEast BioAnalytical Laboratories LLC.
den_biaoTiZhungShi

Related Reports

Global Meso Scale Discovery (MSD) Assay Services Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Service & Software

Published Date: 2026-03-26

Pages: 138 Pages

Report ld: 6342161

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now